# US 2026/0028683 A1 · Assays for fungal infection

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0028683 A1
- Document ID: US20260028683A1
- Status: Published application
- Kind: A1
- Application number: 19/353,138
- Filed: 2025-10-08
- Published: 2026-01-29
- Earliest claimed: 2006-11-02
- Assignees: Rutgers, The State University of New Jersey
- Applicants: Rutgers, The State University of New Jersey
- Inventors: Steven Park; David S. Perlin
- Web page: https://patentgrep.com/patent/US20260028683A1

## CPC

- C12Q 1/6895: for plants, fungi or algae
- C12Q 2600/16: Primer sets for multiplex assays
- C12Q 2600/166: Oligonucleotides used as internal standards, controls or normalisation probes
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

Methods and kits are described for testing for the presence or absence of any fungus in a sample. Examples of fungi that can be detected include, but are not limited to, those belonging to the genera Candida, Aspergillus and Pneumocystis. The methods include obtaining a sample suspected of containing fungal nucleic acid, including at least one universal region of fungal nucleic acid, and testing for the presence or absence in the sample of the at least one universal region of fungal nucleic acid. Samples may be biological or non-biological.

## Claims

### Claim 1

A kit for testing for the presence or absence of at least one region of fungal nucleic acid characteristic of the species Candida tropicalis comprising SEQ ID NO: 30, the complement or transcript thereof, or a sequence having 80% or more sequence identity with SEQ ID NO: 30, the complement or transcript thereof, in a human clinical sample comprising a molecular beacon probe comprising SEQ ID NO: 33 and a pair of primers comprising SEQ ID NO: 31 and SEQ ID NO: 32.

### Claim 2

A kit for testing for the presence or absence of at least one region of fungal nucleic acid characteristic of the species Candida parapsilosis comprising SEQ ID NO: 34, the complement or transcript thereof, or a sequence having 80% or more sequence identity with SEQ ID NO: 34, the complement or transcript thereof, in a human clinical sample comprising a molecular beacon probe comprising SEQ ID NO: 35 and a pair of primers comprising SEQ ID NO: 31 and SEQ ID NO: 32.

### Claim 3

A kit for testing for the presence or absence of at least one region of fungal nucleic acid characteristic of the species Candida albicans comprising SEQ ID NO: 36, the complement or transcript thereof, or a sequence having 80% or more sequence identity with SEQ ID NO: 36, the complement or transcript thereof, in a human clinical sample comprising a molecular beacon probe comprising SEQ ID NO: 37 and a pair of primers comprising SEQ ID NO: 31 and SEQ ID NO: 32.

### Claim 4

A kit for testing for the presence or absence of at least one region of fungal nucleic acid characteristic of the species Candida glabrata comprising SEQ ID NO: 38, the complement or transcript thereof, or a sequence having 80% or more sequence identity with SEQ ID NO: 38, the complement or transcript thereof, in a human clinical sample comprising a molecular beacon probe comprising SEQ ID NO: 39 and a pair of primers comprising SEQ ID NO: 31 and SEQ ID NO: 32.

### Claim 5

A kit for testing for the presence or absence of at least one region of fungal nucleic acid characteristic of the species Candida krusei comprising SEQ ID NO: 40, the complement or transcript thereof, or a sequence having 80% or more sequence identity with SEQ ID NO: 40, the complement or transcript thereof, in a human clinical sample comprising a molecular beacon probe comprising SEQ ID NO: 43 and a pair of primers comprising SEQ ID NO: 31 and SEQ ID NO: 32, a pair of primers comprising SEQ ID NO: 41 and 42, or a combination thereof.
